Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role and Mechanism of Bifidobacterium Triple Viable Capsules in Improving Motor Symptoms in Patients With Mild to Moderate Parkinson's Disease: a Multicenter Randomized Clinical Study

NCT04871464 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT04871464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role and Mechanism of Bifidobacterium Triple Viable Capsules in Improving Motor Symptoms in Patients With Mild to Moderate Parkinson's Disease: a Multicenter Randomized Clinical Study
Lead sponsor
Beijing Friendship Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 11, 2021
Completion date
December 31, 2023
Enrollment
240 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

basal ganglia diseases, brain diseases, central nervous system diseases, movement disorders, nervous system diseases, neurodegenerative diseases, parkinson disease, parkinsonian disorders